Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

BACKGROUND: Breast cancer with pathological non-complete response (non-pCR) after neoadjuvant chemotherapy (NAC) has a worse prognosis. Despite Neo-Bioscore has been validated as an independent prognostic model for breast cancer submitted to NAC, non-pCR carcinoma was not assessed in this setting. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Resende, Uanderson, Cabello, César, Ramalho, Susana Oliveira Botelho, Zeferino, Luiz Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580604/
https://www.ncbi.nlm.nih.gov/pubmed/31208353
http://dx.doi.org/10.1186/s12885-019-5812-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580604/
https://www.ncbi.nlm.nih.gov/pubmed/31208353
http://dx.doi.org/10.1186/s12885-019-5812-0

Ejemplares similares